Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,922 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regulation of Cell and Gene Therapy Medicinal Products in Taiwan.
Lin YC, Wang PY, Tsai SC, Lin CL, Tai HY, Lo CF, Wu SI, Chiang YM, Liu LL. Lin YC, et al. Among authors: lin cl. Adv Exp Med Biol. 2015;871:181-94. doi: 10.1007/978-3-319-18618-4_10. Adv Exp Med Biol. 2015. PMID: 26374219 Review.
Update on Regulation of Regenerative Medicine in Taiwan.
Chao WY, Chang YT, Tsai YT, Huang MC, Lin YC, Wu MM, Chi JF, Lin CL, Cheng HF, Wu SM. Chao WY, et al. Among authors: lin yc, lin cl. Adv Exp Med Biol. 2023;1430:211-219. doi: 10.1007/978-3-031-34567-8_12. Adv Exp Med Biol. 2023. PMID: 37526850
Study on occupational safety and health strategy for Taiwan.
Chuang KY, Su TS, Kuo CY, Lin CL, Lin HY, Yu YC. Chuang KY, et al. Among authors: lin hy, lin cl. Ind Health. 2009 Dec;47(6):656-63. doi: 10.2486/indhealth.47.656. Ind Health. 2009. PMID: 19996542 Free article.
TFDA takes actions to expedite the development of COVID-19 vaccines.
Liu SC, Liu CP, Lin CL. Liu SC, et al. Among authors: lin cl. J Formos Med Assoc. 2022 Apr;121(4):733-735. doi: 10.1016/j.jfma.2021.02.020. Epub 2021 Mar 3. J Formos Med Assoc. 2022. PMID: 33752922 Free PMC article. No abstract available.
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
Liu CH, Chang YP, Lee JY, Chen CY, Kao WY, Lin CL, Yang SS, Shih YL, Peng CY, Lee FJ, Tsai MC, Huang SC, Su TH, Tseng TC, Liu CJ, Chen PJ, Kao JH. Liu CH, et al. Among authors: lin cl. J Med Virol. 2024 May;96(5):e29675. doi: 10.1002/jmv.29675. J Med Virol. 2024. PMID: 38746997
Nonvolatile Modulation of Bi2O2Se/Pb(Zr,Ti)O3 Heteroepitaxy.
Wang YJ, Yang ZL, Chen JW, Zhu R, Hsieh SH, Chang SH, Lin HY, Lin CL, Chen YC, Chen CH, Huang BC, Chiu YP, Yeh CH, Gao P, Chiu PW, Chen YC, Chu YH. Wang YJ, et al. Among authors: lin cl. ACS Appl Mater Interfaces. 2024 May 15. doi: 10.1021/acsami.4c02525. Online ahead of print. ACS Appl Mater Interfaces. 2024. PMID: 38745497
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.
Yang CC, Huang CF, Chang TS, Lo CC, Hung CH, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Wang SJ, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Kuo HT, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Tseng KC, Chen CY, Yu ML. Yang CC, et al. Among authors: lin cl. Infect Dis Ther. 2024 Apr 28. doi: 10.1007/s40121-024-00968-5. Online ahead of print. Infect Dis Ther. 2024. PMID: 38679663
2,922 results